Viewing Study NCT02004392


Ignite Creation Date: 2025-12-24 @ 3:26 PM
Ignite Modification Date: 2026-02-25 @ 11:08 PM
Study NCT ID: NCT02004392
Status: TERMINATED
Last Update Posted: 2016-05-03
First Post: 2013-11-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Sponsor: FORUM Pharmaceuticals Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06
Start Date Type: None
Primary Completion Date: 2017-08
Primary Completion Date Type: ESTIMATED
Completion Date: 2017-08
Completion Date Type: ESTIMATED
First Submit Date: 2013-11-27
First Submit QC Date: None
Study First Post Date: 2013-12-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-05-02
Last Update Post Date: 2016-05-03
Last Update Post Date Type: ESTIMATED